
Bacterial Enzymes as Targets for Drug Discovery by Punit Kaur
Bacterial Enzymes as Targets for Drug Discovery: Meeting the Challenges of Antibiotic Resistance addresses the gap between medical microbiology, structural biology, and genomic science in the development of new antibacterial drug development. This book consolidates detailed profiling of bacterial target enzyme families for the drug discovery process and methodologies for use and validation of the potential drug targets. The contents cover the foundations of the antibiotic drug discovery process and focus on bacterial enzymes as drug targets, building across these disciplines to provide a comprehensive resource in bacterial structural biology and genomics. This is the ideal reference for antibiotic drug discovery researchers in the pharma industry and academia. Biochemists, microbiologists, and medicinal chemists will also benefit from this books’ content.- Plant Peptides
-
Carrier-Free Enzyme Immobilization
-
Lipases
-
Super-Resolution Nanoscopy for Protein Imaging
-
RNases in Health and Diseases
-
Proteolytic Enzymes and their Inhibitors in Infectious Pathogens
-
Isothermal Titration Calorimetry in Enzymology
-
Cryptic Enzymes and Moonlighting Proteins
-
Whole Cell Biocatalysis
-
Enzymatic Production of Oligosaccharides
-
Sustainable Process Intensification for Biocatalysis
-
Ureases
-
Transglutaminase
Dr. Kaur’s specialties include Bioinformatics, Structural Biology, X-ray Crystallography, and Rational Structure-Based Drug Design. Her research focuses on clinically relevant bacterial pathogens where a multidisciplinary approach is adopted to understand the antibacterial resistance mechanisms and design of novel inhibitory molecules. She has published more than 240 original publications, reviews and chapters in the field of bioinformatics, biophysical enzymatic activity and structural biology. Dr. Priyanka Sharma is a postdoctoral student with the biomedical Informatics department at the ICMR. Her work focuses on the field of computational biology involving structural bioinformatics and genomics of bacterial pathogens. She has published widely in the field of clinical bacteriology and is the author of over 30 research papers, reviews and chapters. She has work experience in field of antimicrobial resistance due to enzymatic mutations.
| SKU | Unavailable |
| ISBN 13 | 9780443222221 |
| ISBN 10 | 0443222223 |
| Title | Bacterial Enzymes as Targets for Drug Discovery |
| Author | Punit Kaur |
| Series | Foundations And Frontiers In Enzymology |
| Condition | Unavailable |
| Binding Type | Paperback |
| Publisher | Elsevier Science Publishing Co Inc |
| Year published | 2024-11-28 |
| Number of pages | 496 |
| Cover note | Book picture is for illustrative purposes only, actual binding, cover or edition may vary. |
| Note | Unavailable |











